Tanggung Jawab Perusahaan Farmasi dan BPOM Terhadap Produk Obat Sirup Anak

Agil Ahmad (Fakultas Hukum Institut Ilmu Sosial dan Bisnis Andi Sapada)
Nova Krisyananti (Fakultas Hukum Institut Ilmu Sosial dan Bisnis Andi Sapada)
Muh. Rafli Rumbia (Fakultas Hukum Institut Ilmu Sosial dan Bisnis Andi Sapada)
Susanti Susanti (Fakultas Hukum Institut Ilmu Sosial dan Bisnis Andi Sapada)
Moch Al Farih Rahim (Fakultas Hukum Institut Ilmu Sosial dan Bisnis Andi Sapada)
Aslinda Aslinda (Fakultas Hukum Institut Ilmu Sosial dan Bisnis Andi Sapada)
Muh. Alfayed Suherman (Fakultas Hukum Institut Ilmu Sosial dan Bisnis Andi Sapada)
Putri Rifdah Amalia (Fakultas Hukum Institut Ilmu Sosial dan Bisnis Andi Sapada)

Jurnal Litigasi Amsir
2022: (Special Issue) September-Oktober

Acute kidney failure caused by contaminated FG and DFG syrup drugs mixed with children's syrup drugs. Several other causes that allow kidney failure to occur have been ruled out because it is not proven that the Ministry of Health is working with BPOM to conduct research on recommended drugs for research.Health workers and the pharmaceutical industry are also encouraged by BPOM to continue to actively report drug side effects or unwanted events after drug unemployment to the national pharmaceutical center through the e-Meso mobile application.BPOM supervises business actors to ensure the safety of the raw materials used. This is due to the high level of contamination in syrup medicines which cannot be separated from the responsibility of the drug producer or industry.